BJOG: An International Journal of Obstetrics and Gynaecology
BJOG: An International Journal of Obstetrics and Gynaecology
5 years ago

Inadequate safety reporting in pre-eclampsia trials. A systematic evaluation

Martin Hirsch, Richard J. McManus, Khalid S. Khan, James M. N. Duffy, Sue Ziebland, Marian Showell, , Louise Pealing
Background Randomised trials and their syntheses in meta-analyses offer a unique opportunity to assess the frequency and severity of adverse reactions. Objective To assess safety reporting in pre-eclampsia trials. Search strategy Systematic search using bibliographic databases, including Cochrane Central Register of Controlled Trials, Embase, and MEDLINE, from inception to August 2017. Selection criteria Randomised trials evaluating anticonvulsant or antihypertensive medication for pre-eclampsia. Data collection and analysis Descriptive statistics appraising the adequacy of adverse reaction and toxicity reporting. Main results We included 60 randomised trials. Six trials (10%) were registered with the International Clinical Trials Registry Platform, two registry records referred to adverse reactions, stating “safety and toleration” and “possible side effects” would be collected. Twenty-six trials (43%) stated the frequency of withdrawals within each study arm and five (8%) trials adequately reported these withdrawals. Adverse reactions were inconsistently reported across eligible trials: 24 (40%) reported no serious adverse reactions and 36 (60%) reported no mild adverse reactions. The methods of definition or measurement of adverse reactions were infrequently reported within published trial reports. Conclusions Pre-eclampsia trials regularly omit critical information related to safety. Despite the paucity of reporting, randomised trials collect an enormous amount of safety data. Developing and implementing a minimum data set could help to improve safety reporting, permitting a more balanced assessment of interventions considering the trade-off between the benefits and harms. This article is protected by copyright. All rights reserved.

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.1111/1471-0528.14969

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.